Table 3.
Effects of evacetrapib on 24-h ambulatory blood pressure
| Treatment group | n | Day 1 mean (mmHg) | Day 14 mean (mmHg) | LS mean change (mmHg) | Difference | Comparison with placebo | P-value |
|---|---|---|---|---|---|---|---|
| Systolic blood pressure | |||||||
| Placebo | 13 | 109.29 (105.02, 113.57) | 118.34 (115.54, 121.14) | 1.69 (−0.68, 4.07) | |||
| Evacetrapib 600 mg | 14 | 112.16 (109.12, 115.19) | 118.28 (113.78, 122.77) | −0.27 (−2.64, 2.11) | −1.96 | (−5.32, 1.40) | 0.327 |
| Diastolic blood pressure | |||||||
| Placebo | 13 | 67.55 (63.39, 71.71) | 74.56 (72.00, 77.12) | 2.88 (0.83, 4.93) | |||
| Evacetrapib 600 mg | 14 | 68.27 (64.82, 71.72) | 73.72 (70.26, 77.18) | 0.60 (−1.45, 2.65) | −2.28 | (−5.18, 0.62) | 0.191 |
CI, confidence interval; LS mean, least-squares mean; mmHg, millimetres of mercury; n, number. Results are expressed as means (90% CI).